Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease
BACE-1 is considered to be one of the targets for prevention and treatment of Alzheimer's disease (AD). We here report a novel class of semi-synthetic derivatives of prenylated isoflavones, obtained from the derivatization of natural flavonoids from Maclu
Ribaudo, Giovanni,Coghi, Paolo,Zanforlin, Enrico,Law, Betty Yuen Kwan,Wu, Yuki Yu Jun,Han, Yu,Qiu, Alena Congling,Qu, Yuan Qing,Zagotto, Giuseppe,Wong, Vincent Kam Wai
p. 474 - 483
(2019/03/29)
More Articles about upstream products of 5745-54-0